======= LRRC16A ======= == Gene Information == * **Official Symbol**: CARMIL1 * **Official Name**: capping protein regulator and myosin 1 linker 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55604|55604]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5VZK9|Q5VZK9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LRRC16A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LRRC16A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609593|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Cell membrane-cytoskeleton-associated protein that plays a role in the regulation of actin polymerization at the barbed end of actin filaments. Prevents F-actin heterodimeric capping protein (CP) activity at the leading edges of migrating cells, and hence generates uncapped barbed ends and enhances actin polymerization, however, seems unable to nucleate filaments (PubMed:16054028). Plays a role in lamellipodial protrusion formations and cell migration (PubMed:19846667). {ECO:0000269|PubMed:16054028, ECO:0000269|PubMed:19846667}. No Pfam Domain information is available for this gene. |barbed-end actin filament uncapping| |actin filament uncapping| |negative regulation of barbed-end actin filament capping| |regulation of barbed-end actin filament capping| |actin filament network formation| |macropinocytosis| |macropinosome| |pinocytosis| |urate metabolic process| |positive regulation of actin filament depolymerization| |positive regulation of protein depolymerization| |ruffle organization| |positive regulation of lamellipodium organization| |filamentous actin| |lamellipodium assembly| |positive regulation of protein complex disassembly| |positive regulation of substrate adhesion-dependent cell spreading| |lamellipodium organization| |regulation of lamellipodium organization| |cell leading edge| |positive regulation of stress fiber assembly| |regulation of actin filament depolymerization| |regulation of substrate adhesion-dependent cell spreading| |positive regulation of actin filament bundle assembly| |regulation of stress fiber assembly| |regulation of protein depolymerization| |regulation of actomyosin structure organization| |positive regulation of actin filament polymerization| |regulation of actin filament bundle assembly| |regulation of protein complex disassembly| |positive regulation of cell-substrate adhesion| |positive regulation of protein polymerization| |positive regulation of cell morphogenesis involved in differentiation| |regulation of actin filament polymerization| |lamellipodium| |regulation of actin polymerization or depolymerization| |regulation of actin filament length| |positive regulation of supramolecular fiber organization| |regulation of cell-substrate adhesion| |positive regulation of cytoskeleton organization| |regulation of protein polymerization| |actin filament organization| |positive regulation of protein complex assembly| |regulation of actin filament organization| |protein-containing complex binding| |blood coagulation| |coagulation| |hemostasis| |regulation of cell morphogenesis involved in differentiation| |regulation of actin cytoskeleton organization| |regulation of supramolecular fiber organization| |purine-containing compound metabolic process| |regulation of cellular component size| |positive regulation of cell projection organization| |regulation of actin filament-based process| |nuclear speck| |positive regulation of cell adhesion| |plasma membrane bounded cell projection assembly| |regulation of protein complex assembly| |supramolecular fiber organization| |cell projection assembly| |wound healing| |regulation of cell morphogenesis| |actin cytoskeleton organization| |regulation of body fluid levels| |positive regulation of cell migration| |regulation of anatomical structure size| |positive regulation of cellular component biogenesis| |positive regulation of cell motility| |positive regulation of cellular component movement| |regulation of cytoskeleton organization| |positive regulation of cell development| |positive regulation of locomotion| |endocytosis| |actin filament-based process| |response to wounding| |positive regulation of organelle organization| |import into cell| |regulation of cell adhesion| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |regulation of cell migration| |regulation of cell motility| |regulation of cell development| |regulation of cellular component biogenesis| |cell migration| |positive regulation of cell differentiation| |regulation of locomotion| |regulation of cellular component movement| |organic acid metabolic process| |regulation of anatomical structure morphogenesis| |localization of cell| |cell motility| |cytoskeleton organization| |plasma membrane bounded cell projection organization| |cell projection organization| |positive regulation of cellular component organization| |regulation of organelle organization| |locomotion| |positive regulation of developmental process| |movement of cell or subcellular component| |small molecule metabolic process| |regulation of cell differentiation| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-2.74| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.7| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-2.27| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|-2.16| |[[:results:exp33|Rotenone 2μM R00 exp33]]|-1.94| |[[:results:exp11|CCCP 1μM R00 exp11]]|-1.9| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-1.84| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-1.75| |[[:results:exp17|DABN 20μM R00 exp17]]|-1.74| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13699 * **Expression level (log2 read counts)**: 2.99 {{:chemogenomics:nalm6 dist.png?nolink |}}